Global siRNA Drugs Market Insights, Forecast to 2029
This report presents an overview of global market for siRNA Drugs market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of siRNA Drugs, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for siRNA Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the siRNA Drugs revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global siRNA Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for siRNA Drugs revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Alnylam, Novartis, Sirnaomics and Ribo Life Science, etc.
By Company
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of siRNA Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of siRNA Drugs companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, siRNA Drugs revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
This report researches the key producers of siRNA Drugs, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for siRNA Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the siRNA Drugs revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global siRNA Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for siRNA Drugs revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Alnylam, Novartis, Sirnaomics and Ribo Life Science, etc.
By Company
- Alnylam
- Novartis
- Sirnaomics
- Ribo Life Science
- Without GalNAc-conjugated
- With GalNAc-conjugated
- Genetic Disease
- Cancers
- Other
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East, Africa, and Latin America
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of siRNA Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of siRNA Drugs companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, siRNA Drugs revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global siRNA Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Without GalNAc-conjugated
1.2.3 With GalNAc-conjugated
1.3 Market by Application
1.3.1 Global siRNA Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Genetic Disease
1.3.3 Cancers
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global siRNA Drugs Market Perspective (2018-2029)
2.2 Global siRNA Drugs Growth Trends by Region
2.2.1 siRNA Drugs Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 siRNA Drugs Historic Market Size by Region (2018-2023)
2.2.3 siRNA Drugs Forecasted Market Size by Region (2024-2029)
2.3 siRNA Drugs Market Dynamics
2.3.1 siRNA Drugs Industry Trends
2.3.2 siRNA Drugs Market Drivers
2.3.3 siRNA Drugs Market Challenges
2.3.4 siRNA Drugs Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Revenue siRNA Drugs by Players
3.1.1 Global siRNA Drugs Revenue by Players (2018-2023)
3.1.2 Global siRNA Drugs Revenue Market Share by Players (2018-2023)
3.2 Global siRNA Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of siRNA Drugs, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global siRNA Drugs Market Concentration Ratio
3.4.1 Global siRNA Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by siRNA Drugs Revenue in 2022
3.5 Global Key Players of siRNA Drugs Head office and Area Served
3.6 Global Key Players of siRNA Drugs, Product and Application
3.7 Global Key Players of siRNA Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 SIRNA DRUGS BREAKDOWN DATA BY TYPE
4.1 Global siRNA Drugs Historic Market Size by Type (2018-2023)
4.2 Global siRNA Drugs Forecasted Market Size by Type (2024-2029)
5 SIRNA DRUGS BREAKDOWN DATA BY APPLICATION
5.1 Global siRNA Drugs Historic Market Size by Application (2018-2023)
5.2 Global siRNA Drugs Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America siRNA Drugs Market Size (2018-2029)
6.2 North America siRNA Drugs Market Size by Type
6.2.1 North America siRNA Drugs Market Size by Type (2018-2023)
6.2.2 North America siRNA Drugs Market Size by Type (2024-2029)
6.2.3 North America siRNA Drugs Market Share by Type (2018-2029)
6.3 North America siRNA Drugs Market Size by Application
6.3.1 North America siRNA Drugs Market Size by Application (2018-2023)
6.3.2 North America siRNA Drugs Market Size by Application (2024-2029)
6.3.3 North America siRNA Drugs Market Share by Application (2018-2029)
6.4 North America siRNA Drugs Market Size by Country
6.4.1 North America siRNA Drugs Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America siRNA Drugs Market Size by Country (2018-2023)
6.4.3 North America siRNA Drugs Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 EUROPE
7.1 Europe siRNA Drugs Market Size (2018-2029)
7.2 Europe siRNA Drugs Market Size by Type
7.2.1 Europe siRNA Drugs Market Size by Type (2018-2023)
7.2.2 Europe siRNA Drugs Market Size by Type (2024-2029)
7.2.3 Europe siRNA Drugs Market Share by Type (2018-2029)
7.3 Europe siRNA Drugs Market Size by Application
7.3.1 Europe siRNA Drugs Market Size by Application (2018-2023)
7.3.2 Europe siRNA Drugs Market Size by Application (2024-2029)
7.3.3 Europe siRNA Drugs Market Share by Application (2018-2029)
7.4 Europe siRNA Drugs Market Size by Country
7.4.1 Europe siRNA Drugs Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe siRNA Drugs Market Size by Country (2018-2023)
7.4.3 Europe siRNA Drugs Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 CHINA
8.1 China siRNA Drugs Market Size (2018-2029)
8.2 China siRNA Drugs Market Size by Type
8.2.1 China siRNA Drugs Market Size by Type (2018-2023)
8.2.2 China siRNA Drugs Market Size by Type (2024-2029)
8.2.3 China siRNA Drugs Market Share by Type (2018-2029)
8.3 China siRNA Drugs Market Size by Application
8.3.1 China siRNA Drugs Market Size by Application (2018-2023)
8.3.2 China siRNA Drugs Market Size by Application (2024-2029)
8.3.3 China siRNA Drugs Market Share by Application (2018-2029)
9 ASIA (EXCLUDING CHINA)
9.1 Asia siRNA Drugs Market Size (2018-2029)
9.2 Asia siRNA Drugs Market Size by Type
9.2.1 Asia siRNA Drugs Market Size by Type (2018-2023)
9.2.2 Asia siRNA Drugs Market Size by Type (2024-2029)
9.2.3 Asia siRNA Drugs Market Share by Type (2018-2029)
9.3 Asia siRNA Drugs Market Size by Application
9.3.1 Asia siRNA Drugs Market Size by Application (2018-2023)
9.3.2 Asia siRNA Drugs Market Size by Application (2024-2029)
9.3.3 Asia siRNA Drugs Market Share by Application (2018-2029)
9.4 Asia siRNA Drugs Market Size by Region
9.4.1 Asia siRNA Drugs Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia siRNA Drugs Market Size by Region (2018-2023)
9.4.3 Asia siRNA Drugs Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 MIDDLE EAST, AFRICA, AND LATIN AMERICA
10.1 Middle East, Africa, and Latin America siRNA Drugs Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America siRNA Drugs Market Size by Type
10.2.1 Middle East, Africa, and Latin America siRNA Drugs Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America siRNA Drugs Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America siRNA Drugs Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America siRNA Drugs Market Size by Application
10.3.1 Middle East, Africa, and Latin America siRNA Drugs Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America siRNA Drugs Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America siRNA Drugs Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America siRNA Drugs Market Size by Country
10.4.1 Middle East, Africa, and Latin America siRNA Drugs Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America siRNA Drugs Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America siRNA Drugs Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 KEY PLAYERS PROFILES
11.1 Alnylam
11.1.1 Alnylam Company Details
11.1.2 Alnylam Business Overview
11.1.3 Alnylam siRNA Drugs Introduction
11.1.4 Alnylam Revenue in siRNA Drugs Business (2018-2023)
11.1.5 Alnylam Recent Developments
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis siRNA Drugs Introduction
11.2.4 Novartis Revenue in siRNA Drugs Business (2018-2023)
11.2.5 Novartis Recent Developments
11.3 Sirnaomics
11.3.1 Sirnaomics Company Details
11.3.2 Sirnaomics Business Overview
11.3.3 Sirnaomics siRNA Drugs Introduction
11.3.4 Sirnaomics Revenue in siRNA Drugs Business (2018-2023)
11.3.5 Sirnaomics Recent Developments
11.4 Ribo Life Science
11.4.1 Ribo Life Science Company Details
11.4.2 Ribo Life Science Business Overview
11.4.3 Ribo Life Science siRNA Drugs Introduction
11.4.4 Ribo Life Science Revenue in siRNA Drugs Business (2018-2023)
11.4.5 Ribo Life Science Recent Developments
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global siRNA Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Without GalNAc-conjugated
1.2.3 With GalNAc-conjugated
1.3 Market by Application
1.3.1 Global siRNA Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Genetic Disease
1.3.3 Cancers
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global siRNA Drugs Market Perspective (2018-2029)
2.2 Global siRNA Drugs Growth Trends by Region
2.2.1 siRNA Drugs Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 siRNA Drugs Historic Market Size by Region (2018-2023)
2.2.3 siRNA Drugs Forecasted Market Size by Region (2024-2029)
2.3 siRNA Drugs Market Dynamics
2.3.1 siRNA Drugs Industry Trends
2.3.2 siRNA Drugs Market Drivers
2.3.3 siRNA Drugs Market Challenges
2.3.4 siRNA Drugs Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Revenue siRNA Drugs by Players
3.1.1 Global siRNA Drugs Revenue by Players (2018-2023)
3.1.2 Global siRNA Drugs Revenue Market Share by Players (2018-2023)
3.2 Global siRNA Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of siRNA Drugs, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global siRNA Drugs Market Concentration Ratio
3.4.1 Global siRNA Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by siRNA Drugs Revenue in 2022
3.5 Global Key Players of siRNA Drugs Head office and Area Served
3.6 Global Key Players of siRNA Drugs, Product and Application
3.7 Global Key Players of siRNA Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 SIRNA DRUGS BREAKDOWN DATA BY TYPE
4.1 Global siRNA Drugs Historic Market Size by Type (2018-2023)
4.2 Global siRNA Drugs Forecasted Market Size by Type (2024-2029)
5 SIRNA DRUGS BREAKDOWN DATA BY APPLICATION
5.1 Global siRNA Drugs Historic Market Size by Application (2018-2023)
5.2 Global siRNA Drugs Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America siRNA Drugs Market Size (2018-2029)
6.2 North America siRNA Drugs Market Size by Type
6.2.1 North America siRNA Drugs Market Size by Type (2018-2023)
6.2.2 North America siRNA Drugs Market Size by Type (2024-2029)
6.2.3 North America siRNA Drugs Market Share by Type (2018-2029)
6.3 North America siRNA Drugs Market Size by Application
6.3.1 North America siRNA Drugs Market Size by Application (2018-2023)
6.3.2 North America siRNA Drugs Market Size by Application (2024-2029)
6.3.3 North America siRNA Drugs Market Share by Application (2018-2029)
6.4 North America siRNA Drugs Market Size by Country
6.4.1 North America siRNA Drugs Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America siRNA Drugs Market Size by Country (2018-2023)
6.4.3 North America siRNA Drugs Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 EUROPE
7.1 Europe siRNA Drugs Market Size (2018-2029)
7.2 Europe siRNA Drugs Market Size by Type
7.2.1 Europe siRNA Drugs Market Size by Type (2018-2023)
7.2.2 Europe siRNA Drugs Market Size by Type (2024-2029)
7.2.3 Europe siRNA Drugs Market Share by Type (2018-2029)
7.3 Europe siRNA Drugs Market Size by Application
7.3.1 Europe siRNA Drugs Market Size by Application (2018-2023)
7.3.2 Europe siRNA Drugs Market Size by Application (2024-2029)
7.3.3 Europe siRNA Drugs Market Share by Application (2018-2029)
7.4 Europe siRNA Drugs Market Size by Country
7.4.1 Europe siRNA Drugs Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe siRNA Drugs Market Size by Country (2018-2023)
7.4.3 Europe siRNA Drugs Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 CHINA
8.1 China siRNA Drugs Market Size (2018-2029)
8.2 China siRNA Drugs Market Size by Type
8.2.1 China siRNA Drugs Market Size by Type (2018-2023)
8.2.2 China siRNA Drugs Market Size by Type (2024-2029)
8.2.3 China siRNA Drugs Market Share by Type (2018-2029)
8.3 China siRNA Drugs Market Size by Application
8.3.1 China siRNA Drugs Market Size by Application (2018-2023)
8.3.2 China siRNA Drugs Market Size by Application (2024-2029)
8.3.3 China siRNA Drugs Market Share by Application (2018-2029)
9 ASIA (EXCLUDING CHINA)
9.1 Asia siRNA Drugs Market Size (2018-2029)
9.2 Asia siRNA Drugs Market Size by Type
9.2.1 Asia siRNA Drugs Market Size by Type (2018-2023)
9.2.2 Asia siRNA Drugs Market Size by Type (2024-2029)
9.2.3 Asia siRNA Drugs Market Share by Type (2018-2029)
9.3 Asia siRNA Drugs Market Size by Application
9.3.1 Asia siRNA Drugs Market Size by Application (2018-2023)
9.3.2 Asia siRNA Drugs Market Size by Application (2024-2029)
9.3.3 Asia siRNA Drugs Market Share by Application (2018-2029)
9.4 Asia siRNA Drugs Market Size by Region
9.4.1 Asia siRNA Drugs Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia siRNA Drugs Market Size by Region (2018-2023)
9.4.3 Asia siRNA Drugs Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 MIDDLE EAST, AFRICA, AND LATIN AMERICA
10.1 Middle East, Africa, and Latin America siRNA Drugs Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America siRNA Drugs Market Size by Type
10.2.1 Middle East, Africa, and Latin America siRNA Drugs Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America siRNA Drugs Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America siRNA Drugs Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America siRNA Drugs Market Size by Application
10.3.1 Middle East, Africa, and Latin America siRNA Drugs Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America siRNA Drugs Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America siRNA Drugs Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America siRNA Drugs Market Size by Country
10.4.1 Middle East, Africa, and Latin America siRNA Drugs Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America siRNA Drugs Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America siRNA Drugs Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 KEY PLAYERS PROFILES
11.1 Alnylam
11.1.1 Alnylam Company Details
11.1.2 Alnylam Business Overview
11.1.3 Alnylam siRNA Drugs Introduction
11.1.4 Alnylam Revenue in siRNA Drugs Business (2018-2023)
11.1.5 Alnylam Recent Developments
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis siRNA Drugs Introduction
11.2.4 Novartis Revenue in siRNA Drugs Business (2018-2023)
11.2.5 Novartis Recent Developments
11.3 Sirnaomics
11.3.1 Sirnaomics Company Details
11.3.2 Sirnaomics Business Overview
11.3.3 Sirnaomics siRNA Drugs Introduction
11.3.4 Sirnaomics Revenue in siRNA Drugs Business (2018-2023)
11.3.5 Sirnaomics Recent Developments
11.4 Ribo Life Science
11.4.1 Ribo Life Science Company Details
11.4.2 Ribo Life Science Business Overview
11.4.3 Ribo Life Science siRNA Drugs Introduction
11.4.4 Ribo Life Science Revenue in siRNA Drugs Business (2018-2023)
11.4.5 Ribo Life Science Recent Developments
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global siRNA Drugs Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Without GalNAc-conjugated
Table 3. Key Players of With GalNAc-conjugated
Table 4. Global siRNA Drugs Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global siRNA Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global siRNA Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global siRNA Drugs Market Share by Region (2018-2023)
Table 8. Global siRNA Drugs Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global siRNA Drugs Market Share by Region (2024-2029)
Table 10. siRNA Drugs Market Trends
Table 11. siRNA Drugs Market Drivers
Table 12. siRNA Drugs Market Challenges
Table 13. siRNA Drugs Market Restraints
Table 14. Global siRNA Drugs Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global siRNA Drugs Revenue Share by Players (2018-2023)
Table 16. Global Top siRNA Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in siRNA Drugs as of 2022)
Table 17. Global siRNA Drugs Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by siRNA Drugs Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of siRNA Drugs, Headquarters and Area Served
Table 20. Global Key Players of siRNA Drugs, Product and Application
Table 21. Global Key Players of siRNA Drugs, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global siRNA Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global siRNA Drugs Revenue Market Share by Type (2018-2023)
Table 25. Global siRNA Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global siRNA Drugs Revenue Market Share by Type (2024-2029)
Table 27. Global siRNA Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global siRNA Drugs Revenue Share by Application (2018-2023)
Table 29. Global siRNA Drugs Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global siRNA Drugs Revenue Share by Application (2024-2029)
Table 31. North America siRNA Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America siRNA Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America siRNA Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America siRNA Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America siRNA Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America siRNA Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America siRNA Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe siRNA Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe siRNA Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe siRNA Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe siRNA Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe siRNA Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe siRNA Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe siRNA Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 45. China siRNA Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 46. China siRNA Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 47. China siRNA Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 48. China siRNA Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia siRNA Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia siRNA Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia siRNA Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia siRNA Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia siRNA Drugs Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia siRNA Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia siRNA Drugs Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America siRNA Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America siRNA Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America siRNA Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America siRNA Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America siRNA Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America siRNA Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America siRNA Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 63. Alnylam Company Details
Table 64. Alnylam Business Overview
Table 65. Alnylam siRNA Drugs Product
Table 66. Alnylam Revenue in siRNA Drugs Business (2018-2023) & (US$ Million)
Table 67. Alnylam Recent Developments
Table 68. Novartis Company Details
Table 69. Novartis Business Overview
Table 70. Novartis siRNA Drugs Product
Table 71. Novartis Revenue in siRNA Drugs Business (2018-2023) & (US$ Million)
Table 72. Novartis Recent Developments
Table 73. Sirnaomics Company Details
Table 74. Sirnaomics Business Overview
Table 75. Sirnaomics siRNA Drugs Product
Table 76. Sirnaomics Revenue in siRNA Drugs Business (2018-2023) & (US$ Million)
Table 77. Sirnaomics Recent Developments
Table 78. Ribo Life Science Company Details
Table 79. Ribo Life Science Business Overview
Table 80. Ribo Life Science siRNA Drugs Product
Table 81. Ribo Life Science Revenue in siRNA Drugs Business (2018-2023) & (US$ Million)
Table 82. Ribo Life Science Recent Developments
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
Table 1. Global siRNA Drugs Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Without GalNAc-conjugated
Table 3. Key Players of With GalNAc-conjugated
Table 4. Global siRNA Drugs Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global siRNA Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global siRNA Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global siRNA Drugs Market Share by Region (2018-2023)
Table 8. Global siRNA Drugs Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global siRNA Drugs Market Share by Region (2024-2029)
Table 10. siRNA Drugs Market Trends
Table 11. siRNA Drugs Market Drivers
Table 12. siRNA Drugs Market Challenges
Table 13. siRNA Drugs Market Restraints
Table 14. Global siRNA Drugs Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global siRNA Drugs Revenue Share by Players (2018-2023)
Table 16. Global Top siRNA Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in siRNA Drugs as of 2022)
Table 17. Global siRNA Drugs Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by siRNA Drugs Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of siRNA Drugs, Headquarters and Area Served
Table 20. Global Key Players of siRNA Drugs, Product and Application
Table 21. Global Key Players of siRNA Drugs, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global siRNA Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global siRNA Drugs Revenue Market Share by Type (2018-2023)
Table 25. Global siRNA Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global siRNA Drugs Revenue Market Share by Type (2024-2029)
Table 27. Global siRNA Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global siRNA Drugs Revenue Share by Application (2018-2023)
Table 29. Global siRNA Drugs Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global siRNA Drugs Revenue Share by Application (2024-2029)
Table 31. North America siRNA Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America siRNA Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America siRNA Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America siRNA Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America siRNA Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America siRNA Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America siRNA Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe siRNA Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe siRNA Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe siRNA Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe siRNA Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe siRNA Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe siRNA Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe siRNA Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 45. China siRNA Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 46. China siRNA Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 47. China siRNA Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 48. China siRNA Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia siRNA Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia siRNA Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia siRNA Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia siRNA Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia siRNA Drugs Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia siRNA Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia siRNA Drugs Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America siRNA Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America siRNA Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America siRNA Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America siRNA Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America siRNA Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America siRNA Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America siRNA Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 63. Alnylam Company Details
Table 64. Alnylam Business Overview
Table 65. Alnylam siRNA Drugs Product
Table 66. Alnylam Revenue in siRNA Drugs Business (2018-2023) & (US$ Million)
Table 67. Alnylam Recent Developments
Table 68. Novartis Company Details
Table 69. Novartis Business Overview
Table 70. Novartis siRNA Drugs Product
Table 71. Novartis Revenue in siRNA Drugs Business (2018-2023) & (US$ Million)
Table 72. Novartis Recent Developments
Table 73. Sirnaomics Company Details
Table 74. Sirnaomics Business Overview
Table 75. Sirnaomics siRNA Drugs Product
Table 76. Sirnaomics Revenue in siRNA Drugs Business (2018-2023) & (US$ Million)
Table 77. Sirnaomics Recent Developments
Table 78. Ribo Life Science Company Details
Table 79. Ribo Life Science Business Overview
Table 80. Ribo Life Science siRNA Drugs Product
Table 81. Ribo Life Science Revenue in siRNA Drugs Business (2018-2023) & (US$ Million)
Table 82. Ribo Life Science Recent Developments
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global siRNA Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global siRNA Drugs Market Share by Type: 2022 VS 2029
Figure 3. Without GalNAc-conjugated Features
Figure 4. With GalNAc-conjugated Features
Figure 5. Global siRNA Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global siRNA Drugs Market Share by Application: 2022 VS 2029
Figure 7. Genetic Disease Case Studies
Figure 8. Cancers Case Studies
Figure 9. Other Case Studies
Figure 10. siRNA Drugs Report Years Considered
Figure 11. Global siRNA Drugs Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global siRNA Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global siRNA Drugs Market Share by Region: 2022 VS 2029
Figure 14. Global siRNA Drugs Market Share by Players in 2022
Figure 15. Global Top siRNA Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in siRNA Drugs as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by siRNA Drugs Revenue in 2022
Figure 17. North America siRNA Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America siRNA Drugs Market Share by Type (2018-2029)
Figure 19. North America siRNA Drugs Market Share by Application (2018-2029)
Figure 20. North America siRNA Drugs Market Share by Country (2018-2029)
Figure 21. United States siRNA Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada siRNA Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe siRNA Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 24. Europe siRNA Drugs Market Share by Type (2018-2029)
Figure 25. Europe siRNA Drugs Market Share by Application (2018-2029)
Figure 26. Europe siRNA Drugs Market Share by Country (2018-2029)
Figure 27. Germany siRNA Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France siRNA Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. siRNA Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy siRNA Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia siRNA Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries siRNA Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. China siRNA Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 34. China siRNA Drugs Market Share by Type (2018-2029)
Figure 35. China siRNA Drugs Market Share by Application (2018-2029)
Figure 36. Asia siRNA Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 37. Asia siRNA Drugs Market Share by Type (2018-2029)
Figure 38. Asia siRNA Drugs Market Share by Application (2018-2029)
Figure 39. Asia siRNA Drugs Market Share by Region (2018-2029)
Figure 40. Japan siRNA Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. South Korea siRNA Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. China Taiwan siRNA Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Southeast Asia siRNA Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. India siRNA Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Australia siRNA Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America siRNA Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America siRNA Drugs Market Share by Type (2018-2029)
Figure 48. Middle East, Africa, and Latin America siRNA Drugs Market Share by Application (2018-2029)
Figure 49. Middle East, Africa, and Latin America siRNA Drugs Market Share by Country (2018-2029)
Figure 50. Brazil siRNA Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Mexico siRNA Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Turkey siRNA Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia siRNA Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Israel siRNA Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. GCC Countries siRNA Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Alnylam Revenue Growth Rate in siRNA Drugs Business (2018-2023)
Figure 57. Novartis Revenue Growth Rate in siRNA Drugs Business (2018-2023)
Figure 58. Sirnaomics Revenue Growth Rate in siRNA Drugs Business (2018-2023)
Figure 59. Ribo Life Science Revenue Growth Rate in siRNA Drugs Business (2018-2023)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Figure 1. Global siRNA Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global siRNA Drugs Market Share by Type: 2022 VS 2029
Figure 3. Without GalNAc-conjugated Features
Figure 4. With GalNAc-conjugated Features
Figure 5. Global siRNA Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global siRNA Drugs Market Share by Application: 2022 VS 2029
Figure 7. Genetic Disease Case Studies
Figure 8. Cancers Case Studies
Figure 9. Other Case Studies
Figure 10. siRNA Drugs Report Years Considered
Figure 11. Global siRNA Drugs Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global siRNA Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global siRNA Drugs Market Share by Region: 2022 VS 2029
Figure 14. Global siRNA Drugs Market Share by Players in 2022
Figure 15. Global Top siRNA Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in siRNA Drugs as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by siRNA Drugs Revenue in 2022
Figure 17. North America siRNA Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America siRNA Drugs Market Share by Type (2018-2029)
Figure 19. North America siRNA Drugs Market Share by Application (2018-2029)
Figure 20. North America siRNA Drugs Market Share by Country (2018-2029)
Figure 21. United States siRNA Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada siRNA Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe siRNA Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 24. Europe siRNA Drugs Market Share by Type (2018-2029)
Figure 25. Europe siRNA Drugs Market Share by Application (2018-2029)
Figure 26. Europe siRNA Drugs Market Share by Country (2018-2029)
Figure 27. Germany siRNA Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France siRNA Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. siRNA Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy siRNA Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia siRNA Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries siRNA Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. China siRNA Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 34. China siRNA Drugs Market Share by Type (2018-2029)
Figure 35. China siRNA Drugs Market Share by Application (2018-2029)
Figure 36. Asia siRNA Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 37. Asia siRNA Drugs Market Share by Type (2018-2029)
Figure 38. Asia siRNA Drugs Market Share by Application (2018-2029)
Figure 39. Asia siRNA Drugs Market Share by Region (2018-2029)
Figure 40. Japan siRNA Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. South Korea siRNA Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. China Taiwan siRNA Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Southeast Asia siRNA Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. India siRNA Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Australia siRNA Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America siRNA Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America siRNA Drugs Market Share by Type (2018-2029)
Figure 48. Middle East, Africa, and Latin America siRNA Drugs Market Share by Application (2018-2029)
Figure 49. Middle East, Africa, and Latin America siRNA Drugs Market Share by Country (2018-2029)
Figure 50. Brazil siRNA Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Mexico siRNA Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Turkey siRNA Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia siRNA Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Israel siRNA Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. GCC Countries siRNA Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Alnylam Revenue Growth Rate in siRNA Drugs Business (2018-2023)
Figure 57. Novartis Revenue Growth Rate in siRNA Drugs Business (2018-2023)
Figure 58. Sirnaomics Revenue Growth Rate in siRNA Drugs Business (2018-2023)
Figure 59. Ribo Life Science Revenue Growth Rate in siRNA Drugs Business (2018-2023)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
